The therapeutic potential of Crocus sativus Linn.: A comprehensive narrative review of clinical trials

Phytother Res. 2022 Jan;36(1):98-111. doi: 10.1002/ptr.7286. Epub 2021 Sep 17.

Abstract

Crocus sativus Linn. (Saffron) is valued worldwide for its potential use in the management of various degenerative disorders, including cardiovascular diseases (CVDs), diabetes, cancer, metabolic syndrome (MetS), neurodegenerative diseases, immune disorders, and sexual dysfunction. Previous reports, based on clinical trials, suggest that crocetin, crocin, picrocrocin, and safranal are the main bioactive components of saffron with antioxidant, anti-inflammatory, and anti-apoptotic effects. In this comprehensive narrative review, we studied the recent clinical trials, investigating the medicinal applications of saffron and/or its components. The present results can provide important insights into the potential of saffron in preventing and treating different disorders, with a special focus on the underlying cellular and molecular mechanisms. However, further high-quality studies are needed to firmly establish the clinical efficacy of saffron in treating some degenerative diseases.

Keywords: Crocus sativus Linn.; anti-inflammatory; antioxidant; saffron.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents
  • Antioxidants / pharmacology
  • Crocus*
  • Humans
  • Metabolic Syndrome*
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Plant Extracts